FOXL2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12 results for “FOXL2”

Trials

Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2

30 participants · First posted Oct 3, 2006

PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis

First posted Aug 13, 2019

Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.

35 participants · First posted Apr 26, 2019

Drugs

LOXL2 inhibitors (InterMune)

dual LOX/LOXL2 inhibitors (University of Manchester)

News

Novel Mouse Model and Organoid Program Advance Drug Discovery for Adult Granulosa Cell Tumors

Cross-Species Single-Cell Atlas Reveals Conserved and Divergent Programs in Mammalian Fetal Ovarian Development

FGF18 Emerges as Promising Therapeutic Target for Post-Traumatic Osteoarthritis Through FOXN2 Pathway

Page 1 of 2